Modifier 25 and Modifier 59: When to Use Them, Why They Get Denied, and How to Win the Appeal

By Nasar Haq | June 29, 2026 | 13 min read | Updated: June 29, 2026

Quick Summary: Modifier 25 and 59 account for 38% of all modifier-related denials. This guide covers the exact documentation needed, payer-specific rules for Medicare vs. commercial plans, appeal letter templates, and when to use the newer XE/XP/XS/XU alternatives.

If your practice performs any procedures alongside evaluation and management visits — biopsies with office visits, injections with exams, multiple procedures on the same patient in the same session — you are using modifier 25 and modifier 59. And statistically, you are losing money on both.

These two modifiers are among the most commonly appended in all of medical coding, and they generate more denials, more audit scrutiny, and more revenue leakage than any other modifier pair. The problem is not that billers and coders do not know what modifier 25 and 59 mean. The problem is that the documentation behind them does not meet the specific threshold payers require — and that threshold varies by payer, by specialty, and by the specific procedure-E/M combination being billed.

This guide goes beyond definitions. If you need a reference lookup for all modifiers, see our complete medical billing modifiers guide. This article is the deep dive: real denial scenarios, the exact documentation language that gets claims paid, payer-by-payer rule differences, appeal letter frameworks, and the X-modifier alternatives that are reducing denials for the practices already using them.

• 38% Of Modifier-Related Denials - Attributed to modifier 25 and 59 errors
• 65%+ Appeal Success Rate - When proper documentation is included
• 14-23% Denial Reduction - After switching from 59 to X-modifiers
• $28K-$85K Annual Revenue at Risk - Per mid-size practice from modifier denials

What Modifier 25 and Modifier 59 Actually Mean

Before diving into scenarios and payer rules, the definitions matter — because most denials trace back to a misunderstanding of what these modifiers actually communicate to the payer. Modifier 25 and modifier 59 solve different problems, apply to different code types, and require different documentation. Using one when you mean the other, or applying either without the right supporting documentation, is the fastest path to a denial.

Modifier 25 — Significant, Separately Identifiable E/M Service

Modifier 25 is appended to an Evaluation and Management (E/M) code to indicate that the E/M service was significant and separately identifiable from another procedure or service performed on the same day by the same provider. The E/M visit must address a clinical issue that goes beyond what is inherently part of the pre-operative or post-operative work included in the procedure code. This modifier applies only to E/M codes (99202-99215, 99221-99223, etc.) — never to procedure codes.

Modifier 59 — Distinct Procedural Service

Modifier 59 is appended to a procedure or service code to indicate that the procedure was distinct and independent from other procedures performed on the same day. The distinction can be based on a different session, different procedure or surgery, different site or organ system, separate incision or excision, separate lesion, or separate injury. Modifier 59 is used to bypass NCCI (National Correct Coding Initiative) edits that would otherwise bundle two procedure codes together. It should only be used when no more specific modifier (such as an anatomic modifier or X-modifier) applies.

Modifier 25: The Most Misused Modifier in Medical Billing

Modifier 25 is the single most frequently appended modifier in outpatient billing. It is also the modifier that the OIG (Office of Inspector General) has placed under audit scrutiny in its Work Plan for over a decade running. The reason: it is routinely appended to E/M codes without the documentation to support it, and it is sometimes used as a reflex — automatically added whenever a procedure is performed on the same day as an E/M visit, regardless of whether the E/M was truly separately identifiable.

The core question modifier 25 answers is straightforward: Did the provider perform a medically necessary E/M service that went above and beyond the work inherent in the procedure itself? Every procedure code includes a certain amount of pre-procedure evaluation. A biopsy includes examining the lesion. A joint injection includes assessing the joint. If the E/M visit only documents the evaluation that is already included in the procedure, modifier 25 is not supported — and the claim will be denied or, worse, paid initially and then recouped in a post-payment audit.

Here is when modifier 25 is correctly applied, and when it is not:

Modifier 59: Unbundling Done Right

Modifier 59 exists to solve one specific problem: NCCI edits. The National Correct Coding Initiative maintains a database of procedure code pairs that Medicare considers inherently bundled — meaning that when both are performed on the same day by the same provider on the same patient, only the higher-valued code should be paid. Modifier 59 tells the payer that the two procedures were genuinely distinct services and should each be paid separately.

The distinction can be based on any of the following: a different anatomic site, a different encounter or session, a different specimen, a different surgery or procedure, a different lesion, or a different injury. The key is that the modifier must reflect a real clinical distinction — not simply a billing desire to get both codes paid. CMS has been explicit that modifier 59 should be used only when no more descriptive modifier is available, which is why the X-modifiers (XE, XP, XS, XU) were introduced in 2015 as more specific alternatives.

Understanding NCCI edits is essential for correct modifier 59 usage. When a code pair has an NCCI edit with a modifier indicator of "1," it means modifier 59 (or an appropriate X-modifier) can be appended to the column 2 code to bypass the edit — but only when the clinical circumstances justify it. When the indicator is "0," the edit cannot be overridden with any modifier. Appending modifier 59 to a code pair with a "0" indicator will result in an automatic denial.

1. Check the NCCI edit table first. Before appending modifier 59, verify that the code pair has an NCCI edit with a modifier indicator of "1." If the indicator is "0," no modifier will override the bundling — the services are considered mutually exclusive or components of a more comprehensive code. You can look up NCCI edits on the CMS NCCI Coding Policy Manual or through your billing software's edit engine.
2. Confirm the clinical distinction. The documentation must clearly establish why the two procedures were distinct. Were they performed on different anatomic sites? Different lesions? Different encounters? If you cannot point to a specific clinical reason documented in the operative note, modifier 59 should not be used.
3. Append modifier 59 to the column 2 code only. In any NCCI code pair, the column 1 code is the higher-valued or more comprehensive code, and the column 2 code is the code that would normally be bundled into it. Modifier 59 goes on the column 2 code — never the column 1 code.
4. Use an X-modifier if one applies. CMS guidance states that modifier 59 should be the modifier of last resort within the 59/X-modifier family. If XE, XP, XS, or XU more precisely describes the reason the procedures were distinct, use that modifier instead.

Modifier 25 vs. Modifier 59: Side-by-Side Comparison

Many billing staff confuse modifier 25 and modifier 59 because both deal with "separate" services on the same day. But they address fundamentally different coding problems and apply to different code types. This table clarifies the distinctions.

XE, XP, XS, XU: The Modifier 59 Alternatives You Should Be Using

In January 2015, CMS introduced four new modifiers — XE, XP, XS, and XU — as more specific alternatives to modifier 59. The intent was to reduce improper use of modifier 59 by requiring practices to specify exactly why two procedures were distinct. While CMS has not eliminated modifier 59, their guidance is clear: use an X-modifier whenever one applies, and reserve modifier 59 only for situations where no X-modifier accurately describes the distinction.

The practical impact has been significant. Across Medtransic's client base of 500+ practices, those that systematically replaced modifier 59 with the appropriate X-modifier saw a 14-23% reduction in bundling-related denials within six months. Payers — particularly Medicare and Aetna — have become increasingly likely to deny modifier 59 claims when an X-modifier would have been more appropriate.

Specialty-Specific Scenarios: Dermatology, Pain Management, and Orthopedics

Modifier 25 and 59 issues are not distributed evenly across specialties. Certain specialties have billing patterns that make these modifiers unavoidable on a high percentage of claims — and that is exactly where denials concentrate. The following scenarios are drawn from real claim patterns Medtransic has managed across these specialties.

Dermatology: Biopsy + E/M (Modifier 25)

Dermatology practices append modifier 25 on a higher percentage of claims than almost any other specialty. A patient comes in with a suspicious lesion, the provider evaluates it and performs a biopsy — this is a standard dermatology billing scenario. But the E/M visit is only separately billable with modifier 25 if the provider documented clinical work beyond what is inherent in the biopsy itself.

Scenario: A patient presents with a changing mole on the left shoulder. During the same visit, the patient also mentions a persistent rash on both forearms that has not responded to over-the-counter treatment. The provider examines the mole, performs a shave biopsy (CPT 11102), and also evaluates the rash — documenting a separate history of the rash, a detailed exam of the forearms, differential diagnosis considerations, and a treatment plan including a prescription topical.

Correct billing: 11102 (shave biopsy) + 99213 or 99214 with modifier 25. The E/M is supported because the rash evaluation required separate clinical decision-making that was not part of the biopsy work. Common mistake: Billing 99213-25 when the only documented reason for the visit was the suspicious mole. If the E/M note only describes the lesion that was biopsied, the E/M is not separately identifiable — it is inherent to the biopsy and will be denied.

Pain Management: Injection + E/M (Modifier 25) and Multiple Injections (Modifier 59/XS)

Pain management billing is a minefield for modifier errors. Providers frequently perform E/M visits alongside injections (requiring modifier 25) and multiple injections at different spinal levels or anatomic sites in the same session (requiring modifier 59 or XS). Both modifiers may appear on the same claim, which multiplies the documentation burden.

Scenario 1 (Modifier 25): A chronic pain patient presents for a scheduled lumbar epidural steroid injection (CPT 62323). During the visit, the provider also evaluates new-onset cervical radiculopathy — documenting a separate cervical spine history, neurological exam of the upper extremities, review of recent cervical MRI findings, and a plan to schedule a cervical epidural. The E/M for the cervical problem is separately identifiable from the lumbar injection.

Scenario 2 (Modifier 59/XS): The same provider performs a facet joint injection at L4-L5 (CPT 64494) and a separate facet joint injection at L3-L4 (CPT 64493). NCCI edits bundle 64494 into 64493. To unbundle, append XS to 64494 to indicate the injection was at a separate anatomic level. The operative note must specify each level injected with fluoroscopic confirmation.

Orthopedics: Global Period Complications and Multiple Procedure Sites

Orthopedic practices face modifier challenges around global surgical periods and multiple procedure sites. When a patient returns during the global period for a problem unrelated to the surgery, modifier 24 applies to the E/M. But when a same-day E/M is performed alongside a procedure — such as evaluating a new injury while performing a scheduled injection — modifier 25 is required.

Scenario: A patient presents for a scheduled right knee corticosteroid injection (CPT 20611). During the visit, the provider also evaluates acute left ankle pain from a weekend injury — documenting a separate history, left ankle exam, X-ray order, assessment of possible fracture, and a treatment plan including immobilization. The left ankle E/M is billed as 99213 or 99214 with modifier 25. The key: two different anatomic sites, two different clinical problems, two separate assessments and plans documented in the note.

Payer-Specific Rules: Medicare vs. Commercial Plans

One of the most costly mistakes in modifier billing is assuming all payers follow the same rules. They do not. Medicare, Aetna, UnitedHealthcare, and BCBS each have distinct policies on modifier 25 and 59 that affect whether your claim gets paid, denied, or flagged for audit. Here are the differences that matter most.

Why Modifier 25 and 59 Claims Get Denied

Modifier-related denials are not random. They follow predictable patterns that, once understood, can be systematically prevented. Across Medtransic's denial management operations, the following are the most common denial reasons for modifier 25 and 59 claims, ranked by frequency.

Top Modifier 25 Denial Reasons

1. E/M documentation does not support a separately identifiable service (45% of modifier 25 denials). The E/M note only describes the problem being treated by the procedure. There is no documentation of a separate chief complaint, separate exam findings, or separate medical decision-making beyond what was needed to decide to perform the procedure.
2. Same diagnosis on E/M and procedure lines (22% of modifier 25 denials). Some payers — especially Aetna and certain BCBS plans — automatically deny when the primary ICD-10 code on the E/M line matches the procedure line. Even when the E/M is legitimately separately identifiable, the diagnosis-matching edit triggers a denial that must be appealed or prevented by linking a distinct ICD-10 to the E/M line.
3. Insufficient E/M level documentation (18% of modifier 25 denials). The E/M level billed (e.g., 99214) is not supported by the documentation complexity. The note may support a 99212 or 99213, or the documentation is templated and lacks specificity. Payers downcode or deny the E/M entirely.
4. Modifier 25 appended to a code that is not an E/M (8% of modifier 25 denials). Billing staff accidentally append modifier 25 to a procedure code instead of the E/M code. Modifier 25 only applies to E/M codes — appending it to a CPT procedure code results in an automatic denial.
5. Global period overlap (7% of modifier 25 denials). The E/M visit falls within the global period of a prior surgery. Modifier 24 — not modifier 25 — is needed to indicate the E/M is unrelated to the prior surgery. Using modifier 25 instead of modifier 24 in this scenario results in denial.

Top Modifier 59 Denial Reasons

1. Documentation does not establish a distinct service (40% of modifier 59 denials). The operative or procedure note does not specify separate anatomic sites, separate lesions, separate encounters, or any other clinical distinction. The note describes both procedures but does not explain why they were independent.
2. NCCI edit indicator is "0" — modifier override not permitted (25% of modifier 59 denials). The code pair has an NCCI edit that does not allow modifier override. No modifier will bypass this edit. The claim is denied regardless of documentation.
3. Modifier 59 used when an X-modifier or anatomic modifier is more appropriate (15% of modifier 59 denials). Increasingly, payers — particularly Medicare — deny modifier 59 when XS, XE, XP, or XU would more precisely describe the distinction. Some MACs (Medicare Administrative Contractors) have begun soft-denying modifier 59 claims with a remittance note recommending X-modifier use.
4. Modifier 59 appended to the wrong code (12% of modifier 59 denials). Modifier 59 should go on the column 2 code in the NCCI pair. Appending it to the column 1 code is incorrect and will not bypass the edit.
5. Both procedures performed on the same anatomic site without clinical distinction (8% of modifier 59 denials). The procedures were performed at the same site, during the same encounter, by the same provider, and the documentation does not establish any basis for treating them as distinct services.

How to Appeal Modifier 25 and 59 Denials — and Win

The good news about modifier 25 and 59 denials: they are among the most winnable appeals in medical billing, provided you submit the right documentation. Across Medtransic's appeal operations, modifier-related appeal success rates exceed 65% — and climb above 80% when the appeal includes a structured cover letter, highlighted clinical notes, and payer-specific references.

Here is the framework we use for modifier appeals:

Modifier 25 Appeal Framework

1. Open with the regulatory definition. State that modifier 25 is defined by the AMA CPT manual and CMS as indicating a "significant, separately identifiable evaluation and management service by the same physician or other qualified health care professional on the same day of the procedure or other service." This establishes the standard the claim should be measured against.
2. Identify the separate clinical problem. Clearly state the clinical issue addressed by the E/M that was separate from the procedure. Example: "The E/M service (99214-25) addressed the patient's new-onset bilateral forearm dermatitis, which is a clinically distinct condition from the suspicious nevus (lesion) that was biopsied during the same visit."
3. Highlight the separate documentation elements. Walk the reviewer through the specific portions of the E/M note that demonstrate separate history, separate examination, and separate medical decision-making. Use page and paragraph references. Highlight or annotate the relevant sections in the attached clinical notes.
4. Address the denial reason directly. If the denial cited "documentation does not support a separately identifiable E/M," respond specifically: "The attached clinical note documents [specific elements] which constitute a separately identifiable E/M service per CMS guidelines."
5. Include the highlighted clinical note. Attach the full E/M note with the separately identifiable components highlighted or annotated. Make it easy for the reviewer to see the distinct service without reading the entire chart.
6. Reference payer-specific policy if applicable. If the payer has a published medical policy on modifier 25, cite it. If the denial contradicts the payer's own published policy, quote the relevant section.

Modifier 59 Appeal Framework

1. Cite the NCCI edit and modifier indicator. State the specific NCCI code pair, confirm the modifier indicator is "1" (allowing modifier override), and reference the NCCI Coding Policy Manual section that permits the use of modifier 59 or X-modifiers when clinical circumstances justify separate reporting.
2. Specify the clinical distinction. State exactly why the procedures were distinct: different anatomic site (specify both sites), different encounter (specify times), different specimen, different lesion (specify locations), or separate surgical field. Be specific — "different site" is not enough; state "right lateral knee vs. left medial ankle."
3. Include operative notes or procedure documentation. Attach the full operative or procedure notes showing each procedure documented separately with distinct anatomic references, separate indications, and separate findings.
4. Include a diagram if applicable. For procedures at different anatomic sites — especially dermatology lesion removals, orthopedic injections, or pain management blocks — a body diagram showing the separate sites dramatically increases appeal success. Many EHR systems can generate anatomic diagrams that can be included with the appeal.
5. State the correct modifier and why it applies. If you used an X-modifier (XS, XE, XP, XU), explain why that specific modifier was chosen and how it accurately describes the clinical distinction.

Documentation Checklist: What You Need in the Chart

Prevention is less expensive than appeals. The following documentation checklist — used by Medtransic's coding team across 500+ practices — ensures modifier 25 and 59 claims are supported before they are submitted. Print this, share it with your providers, and integrate it into your pre-submission claim review process.

Modifier 25 Documentation Requirements

• Separate chief complaint or reason for the E/M. The note must document why the E/M visit was medically necessary beyond the procedure. "Patient also presents with..." or "In addition to the scheduled procedure, the patient reports..." should appear in the note.
• Separate history elements. Document the history of the separate problem — onset, duration, severity, prior treatment. This should be distinct from any history related to the procedure.
• Separate exam findings. Document exam findings related to the separate problem. If the E/M addresses a rash and the procedure is a mole biopsy, the exam section must include findings about the rash — not just the mole.
• Separate assessment and plan. Document a distinct assessment (diagnosis) and a distinct treatment plan for the E/M problem. This is the most critical element — it shows separate medical decision-making.
• Distinct ICD-10 code on the E/M line. When clinically appropriate, link a different diagnosis code to the E/M line than the one linked to the procedure. This prevents automated diagnosis-matching denials from payers like Aetna.
• Avoid templated language. E/M notes that appear to be auto-populated templates with no patient-specific detail are flagged for review. Specificity in documentation is the single strongest defense against modifier 25 denials.

Modifier 59 / X-Modifier Documentation Requirements

• Specify the anatomic site for each procedure. Document the exact location — not just "knee" but "right medial knee" vs. "right lateral knee." Anatomic specificity is essential for XS modifier support.
• Document separate indications for each procedure. Why was each procedure medically necessary independently? Each should have its own clinical rationale.
• Use separate operative or procedure notes when possible. If the procedures were truly distinct, documenting them in separate procedure notes (even if performed during the same encounter) strengthens the case for separate reporting.
• Include laterality and site modifiers. Append RT/LT or anatomic site modifiers in addition to modifier 59 or X-modifiers when applicable. Stacking the correct anatomic modifier with an X-modifier provides multiple data points supporting the claim.
• For XE (separate encounter): document the separate encounter times. If two procedures were performed at different times on the same day, document the start and end times of each encounter separately.
• For XP (separate practitioner): ensure each provider has a separate note. Each practitioner should document their own procedure note to support XP usage.

Sources

• CMS National Correct Coding Initiative (NCCI) Edits — Official NCCI code pair edits, modifier indicators, and coding policy manual for Medicare claims
• AMA CPT Professional Edition — Official CPT modifier definitions including modifier 25 and modifier 59, maintained by the American Medical Association
• HHS Office of Inspector General — Annual Work Plan — Federal audit targets for Medicare billing, including modifier 25 compliance reviews
• CMS NCCI Coding Policy Manual, Chapter 1 — Detailed guidance on modifier 59 and X-modifier (XE, XP, XS, XU) usage, including when modifier 59 should be replaced by a more specific X-modifier
• AAPC (American Academy of Professional Coders) — Coding accuracy benchmarks and modifier usage guidance for professional coders
• MGMA (Medical Group Management Association) — Denial rate benchmarks, modifier-related denial frequency data, and practice management analytics